Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection
Clinical trial NCT03418571 · TERMINATED
Trial details
- NCT number
- NCT03418571
- Sponsor
- Ablynx, a Sanofi company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2018-10-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.